Catalyst Wire Dossier Catalyst Wire Dossier

APL180

· Novartis Pharmaceuticals
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for APL180, covering 2009-11-20 to 2020-12-24. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of APL180 in Healthy Volunteers and Patients With Coronary Heart Disease (CHD) [Phase 1, Phase 2]

See pricing